{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06285916",
            "orgStudyIdInfo": {
                "id": "NORA520-PT-US-1a"
            },
            "organization": {
                "fullName": "Gerbera Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression",
            "officialTitle": "A Randomized, Placebo-Controlled, Double-Blinded, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Oral NORA520 in Female Adults With Severe Postpartum Depression",
            "acronym": "NuMom",
            "therapeuticArea": [
                "Mental Health"
            ],
            "study": "a-study-to-assess-the-efficacy-safety-and-tolerability-of-oral-in-adults-with-severe-postpartum-depression"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-17",
            "studyFirstSubmitQcDate": "2024-02-22",
            "studyFirstPostDateStruct": {
                "date": "2024-02-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Gerbera Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to test the study drug, NORA520, as a possible treatment for severe postpartum depression (PPD). The trial aims to determine:\n\n* How well NORA520 is tolerated and what side effects it may cause\n* If NORA520 reduces depressive symptoms in subjects with severe PPD\n* The amount of NORA520 in the blood at various times after taking the study drug; this provides information that helps determine how often NORA520 should be taken\n* In a subset of subjects, the amount of NORA520 in breastmilk at various times after taking it to determine if and how much NORA520 can pass into breastmilk Participate in this study will be randomly assigned to one of 3 different groups. All subjects will take the study drug for 3 days."
        },
        "conditionsModule": {
            "conditions": [
                "Depression, Postpartum",
                "Postpartum Depression",
                "Post-partum Depression",
                "Postnatal Depression",
                "Post-Natal Depression"
            ],
            "keywords": [
                "Depression",
                "Postpartum Depression",
                "NORA520",
                "Postnatal Depression",
                "NuMom"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 90,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "NORA520 Tablets Dose 1",
                    "type": "EXPERIMENTAL",
                    "description": "NORA520 Tablets Dose 1",
                    "interventionNames": [
                        "Drug: NORA520 Dose 1"
                    ]
                },
                {
                    "label": "NORA520 Tablets Dose 2",
                    "type": "EXPERIMENTAL",
                    "description": "NORA520 Tablets Dose 2",
                    "interventionNames": [
                        "Drug: NORA520 Dose 2"
                    ]
                },
                {
                    "label": "Placebo Tablets",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo Tablets",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NORA520 Dose 1",
                    "description": "Oral NORA520 tablets Dose 1 for 3 days",
                    "armGroupLabels": [
                        "NORA520 Tablets Dose 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "NORA520 Dose 2",
                    "description": "Oral NORA520 tablets Dose 2 for 3 days",
                    "armGroupLabels": [
                        "NORA520 Tablets Dose 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Oral Placebo tablets for 3 days",
                    "armGroupLabels": [
                        "Placebo Tablets"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence, severity, and causality of AEs, SAEs, and AESIs",
                    "description": "Adverse events (AEs), Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESIs)",
                    "timeFrame": "Up to Day 30"
                },
                {
                    "measure": "Change from baseline in HAM-D17 total score compared to placebo",
                    "description": "The Seventeen-Item Hamilton Rating Scale for Depression (HAM-D17) contains 17 individual ratings related to the following symptoms: depressed mood, feelings of guilt, suicide, insomnia (initial, middle, and late), work and interests, psychomotor retardation, psychomotor agitation, anxiety (psychic and somatic), gastrointestinal symptoms, general somatic symptoms, sexual interest, hypochondriasis, insight, and weight loss. The total score ranges from 0 to 52, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Day 4"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in HAM-D17 total score",
                    "description": "The Seventeen-Item Hamilton Rating Scale for Depression (HAM-D17) contains 17 individual ratings related to the following symptoms: depressed mood, feelings of guilt, suicide, insomnia (initial, middle, and late), work and interests, psychomotor retardation, psychomotor agitation, anxiety (psychic and somatic), gastrointestinal symptoms, general somatic symptoms, sexual interest, hypochondriasis, insight, and weight loss. The total score ranges from 0 to 52, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Days 8 and 30"
                },
                {
                    "measure": "HAM-D17 response",
                    "description": "Defined as having a 50% or greater reduction from baseline in HAM-D17 total score. The total score ranges from 0 to 52, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "HAM-D17 remission",
                    "description": "Defined as having a HAM-D17 total score \u22647. The total score ranges from 0 to 52, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "Change from baseline in HAM-D17 subscale and individual item scores",
                    "description": "The Seventeen-Item Hamilton Rating Scale for Depression (HAM-D17) contains 17 individual ratings related to the following symptoms: depressed mood, feelings of guilt, suicide, insomnia (initial, middle, and late), work and interests, psychomotor retardation, psychomotor agitation, anxiety (psychic and somatic), gastrointestinal symptoms, general somatic symptoms, sexual interest, hypochondriasis, insight, and weight loss. The total score ranges from 0 to 52, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "Change from baseline in Clinical Global Impression - Severity (CGI-S) score",
                    "description": "The CGI-S scale is a 7-point scale that requires the Investigator to assess how mentally ill is the patient at this time. 1 - normal, not at all ill; 2 - borderline mentally ill; 3 - mildly ill; 4 - moderately ill; 5 - markedly ill; 6 - severely ill; or 7 - among the most extremely ill patients.",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "Clinical Global Impression - Improvement (CGI-I) scale positive response",
                    "description": "The CGI-I scale is a 7-point scale that requires the Investigator to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of study drug treatment. 1 - very much improved; 2 - much improved; 3 - minimally improved; 4 - no change; 5 - minimally worse; 6 - much worse; or 7 - very much worse",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "Change from baseline in Montgomery-\u00c5sberg Depression Rating Scale (MADRS) total score",
                    "description": "The MADRS contains 10 individual items related to the following symptoms: apparent sadness, reported sadness, inner tension, reduced sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts. The total score ranges from 0 to 60, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "Change from baseline in Hamilton Anxiety Rating Scale (HAM-A) total score",
                    "description": "The HAM-A contains 14 individual ratings related to the following symptoms: anxious mood, tension, fears, insomnia, intellectual, depressed mood, somatic (muscular), somatic (sensory), cardiovascular symptoms, respiratory symptoms, gastrointestinal symptoms, genitourinary symptoms, autonomic symptoms, and behavior at interview. The total score ranges from 0 to 56, with higher scores indicating more severe anxiety.",
                    "timeFrame": "Baseline to Days 4, 8, and 30"
                },
                {
                    "measure": "Change from baseline in Edinburgh Postnatal Depression Scale (EPDS) total score",
                    "description": "The Edinburgh Postnatal Depression Scale (EPDS) is a set of 10 screening questions. The total score ranges from 0 to 30, with higher scores indicating more severe depression.",
                    "timeFrame": "Baseline to Days 8 and 30"
                },
                {
                    "measure": "Number of patients who start any new antidepressant or anti-anxiety medication",
                    "timeFrame": "After Day 8 assessments through Day 30"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Are willing and able to provide signed informed consent to participate in the study and to comply with all study procedures and scheduled visits\n* Are an adult female between 18 and 45 years of age, inclusive;\n* Have either ceased lactating at Screening, or if still lactating or actively breastfeeding at Screening, agree to temporarily cease giving breastmilk to their infant(s) from just prior to first dose of study drug on Day 1 through Day 14;\n* Have a negative pregnancy test at Screening and Day 1 (prior to dosing);\n* Have had a depressive episode that began no earlier than the third trimester and no later than the first 4 weeks following delivery\n* Are \u22649 months postpartum at Screening.\n\nKey Exclusion Criteria:\n\n* Have a history or current diagnosis or current treatment of bipolar disorder, schizophrenia, or schizoaffective disorder;\n* Have had recorded treatment failure of \u22652 different antidepressant classes (e.g., SSRI, SNRI) in the current or previous episode;\n* Are currently experiencing active psychosis per Investigator assessment, or are taking typical or atypical antipsychotic medication;\n* Have a history of suicidal behavior within 2 years;\n* Have a history or current diagnosis of sleep apnea or narcolepsy.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "45 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trial Team",
                    "role": "CONTACT",
                    "phone": "+886-2-8501-2609",
                    "email": "clinicaltrial@gerberarx.com"
                }
            ],
            "locations": [
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Bentonville",
                    "state": "Arkansas",
                    "zip": "72712",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.37285,
                        "lon": -94.20882
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Anaheim",
                    "state": "California",
                    "zip": "92805",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.83529,
                        "lon": -117.9145
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Canoga Park",
                    "state": "California",
                    "zip": "91304",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.20112,
                        "lon": -118.59814
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Sherman Oaks",
                    "state": "California",
                    "zip": "91403",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.15112,
                        "lon": -118.44925
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Torrance",
                    "state": "California",
                    "zip": "90504",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.83585,
                        "lon": -118.34063
                    }
                },
                {
                    "facility": "Gerbera sites",
                    "status": "RECRUITING",
                    "city": "Miami Gardens",
                    "state": "Florida",
                    "zip": "33014",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.94298,
                        "lon": -80.24452
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33145",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32807",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Pompano Beach",
                    "state": "Florida",
                    "zip": "33060",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.23786,
                        "lon": -80.12477
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "state": "Florida",
                    "zip": "33607",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.77086,
                        "lon": -82.67927
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30331",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Columbus",
                    "state": "Georgia",
                    "zip": "31904",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.46098,
                        "lon": -84.98771
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Decatur",
                    "state": "Georgia",
                    "zip": "30030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.77483,
                        "lon": -84.29631
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Savannah",
                    "state": "Georgia",
                    "zip": "31405",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.08354,
                        "lon": -81.09983
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60616",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89121",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Glen Oaks",
                    "state": "New York",
                    "zip": "11004",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.74705,
                        "lon": -73.71152
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Monroe",
                    "state": "North Carolina",
                    "zip": "28112",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.98543,
                        "lon": -80.54951
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "League City",
                    "state": "Texas",
                    "zip": "77573",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.50745,
                        "lon": -95.09493
                    }
                },
                {
                    "facility": "Gerbera site",
                    "status": "RECRUITING",
                    "city": "Richardson",
                    "state": "Texas",
                    "zip": "75080",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.94818,
                        "lon": -96.72972
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019052",
                    "term": "Depression, Postpartum"
                },
                {
                    "id": "D000003863",
                    "term": "Depression"
                },
                {
                    "id": "D000003866",
                    "term": "Depressive Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000019964",
                    "term": "Mood Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000011644",
                    "term": "Puerperal Disorders"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7058",
                    "name": "Depression",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7061",
                    "name": "Depressive Disorder",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21076",
                    "name": "Depression, Postpartum",
                    "asFound": "Postpartum Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M21835",
                    "name": "Mood Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14499",
                    "name": "Puerperal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        }
    },
    "hasResults": false
}